Mehra, Ashna
Grohman, Rebecca
Shah, Sohini
Nowak-Węgrzyn, Anna https://orcid.org/0000-0002-0960-9854
Article History
Accepted: 2 May 2023
First Online: 31 May 2023
Declarations
:
: AM: no competing interests. ANW: Anna Nowak-Wegrzyn receives research support from Alladapt Immunotherapeutics, DBV Technologies, Siolta Therapeutics, and Regeneron; speaking fees from Nestle, Danone, and Thermofisher; royalties from UpToDate; she serves as an Associate Editor for the Annals of Allergy, Asthma and Immunology, Director of the AAAAI Board, and the Chair of the Medical Advisory Board of the International FPIES Association. The other authors declare no competing interests.
: All procedures performed by authors of this paper in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.